Inflammatory profiling of early experimental necrotizing pancreatitis

Life Sciences

Volumn 126, Issue , 2015, Pages 76-80

  Schneider, Lutz ^a   Jabrailova, Bahar ^a   Strobel, Oliver ^a   Hackert, Thilo ^a   Werner, Jens ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute pancreatitis; Cytokines; Experimental; Myeloperoxidase; Necrotizing pancreatitis; Severe pancreatitis; Systemic complications

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; HBP1 PROTEIN, RAT; IL1B PROTEIN, RAT;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME ACTIVITY; INFLAMMATION; LONGITUDINAL STUDY; LUNG; MALE; MEDIATOR RELEASE; MORPHOLOGY; NONHUMAN; PANCREAS; PANCREAS INJURY; RAT; SEVERE NECROTIZING PANCREATITIS; SHAM PROCEDURE; ANIMAL; DISEASE MODEL; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALIA; RATTUS NORVEGICUS;

ANIMALS; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; PANCREATITIS, ACUTE NECROTIZING; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924386511     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.01.029     Document Type: Article

References (35)

1. L. Schneider et al. Acute pancreatitis with an emphasis on infection Infect. Dis. Clin. N. Am. 24 4 2010 921 941 (viii)
2. M.L. Steer Etiology and pathophysiology of acute pancreatitis V.L.V. Go, E.P. Dimagno, J.D. Gardner, E. Lebenthal, A. Reber, G.A. Scheele, The Pancreas: Biology, Pathophysiology, and Disease 1993 Raven New York 581 592
3. V. Gross et al. Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepato-Gastroenterology 40 6 1993 522 530
4. J. Werner et al. Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1 Ann. Surg. 229 6 1999 834 840 (discussion 41-2)
5. J. Norman The role of cytokines in the pathogenesis of acute pancreatitis Am. J. Surg. 175 1 1998 76 83
6. D. Ceranowicz et al. Role of hormonal axis, growth hormone - IGF-1, in the therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis J. Physiol. Pharmacol. 61 5 2010 599 606
7. Q. Chen et al. Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist Pancreas 39 8 2010 1220 1225
8. T. Hackert et al. P-selectin inhibition reduces severity of acute experimental pancreatitis Pancreatology 9 4 2009 369 374
9. T. Hackert et al. Effects of pantoprazole in experimental acute pancreatitis Life Sci. 87 17-18 2010 551 557
10. T. Hackert, and J. Werner Antioxidant therapy in acute pancreatitis: experimental and clinical evidence Antioxid. Redox Signal. 15 10 2011 2767 2777
11. G. Hu et al. Reg4 protects against acinar cell necrosis in experimental pancreatitis Gut 60 6 2011 820 828
12. H.T. Jin et al. Association between remote organ injury and tissue polyamine homeostasis in acute experimental pancreatitis - treatment with a polyamine analogue bismethylspermine Pharmacol. Rep. 63 4 2011 999 1008
13. K.R. Joo et al. Effect of Korean red ginseng on superoxide dismutase inhibitor-induced pancreatitis in rats: a histopathologic and immunohistochemical study Pancreas 38 6 2009 661 666
14. L. Minutoli et al. Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway Crit. Care Med. 39 5 2011 1089 1096
15. A. Paszt et al. Effects of glucocorticoid agonist and antagonist on the pathogenesis of l-arginine-induced acute pancreatitis in rat Pancreas 36 4 2008 369 376
16. R. Pezzilli Pharmacotherapy for acute pancreatitis Expert. Opin. Pharmacother. 10 18 2009 2999 3014
17. F. Polito et al. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis Br. J. Pharmacol. 161 5 2010 1002 1011
18. L. Schneider et al. Effects of gadolinium chloride and glycine on hepatic and pancreatic tissue damage in alcoholic pancreatitis Pancreas 39 4 2010 502 509
19. Y. Tang et al. Sinisan, a traditional chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats J. Hepatobiliary Pancreat. Sci. 18 4 2011 551 558
20. B. Uysal et al. Efficacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis Pancreas 39 1 2010 9 15
21. G. Wang et al. Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis Inflamm. Res. 59 6 2010 479 488
22. J. Werner et al. Multidrug strategies are effective in the treatment of severe experimental pancreatitis Surgery 151 3 2012 372 381
23. X.P. Zhang et al. Protective effects of ligustrazine, Kakonein and Panax Notoginsenoside on the small intestine and immune organs of rats with severe acute pancreatitis Hepatobiliary Pancreat. Dis. Int. 10 6 2011 632 637
24. L. Schneider et al. Inosine reduces microcirculatory disturbance and inflammatory organ damage in experimental acute pancreatitis in rats Am. J. Surg. 191 4 2006 510 514
25. L. Schneider et al. Pharmacological cholinergic stimulation as a therapeutic tool in experimental necrotizing pancreatitis Pancreas 43 1 2014 41 46
26. J. Schmidt et al. A better model of acute pancreatitis for evaluating therapy Ann. Surg. 215 1 1992 44 56
27. W. Hartwig et al. Chemotactic peptide uptake in acute pancreatitis: correlation with tissue accumulation of leukocytes J. Appl. Physiol. 87 2 1999 743 749
28. K.S. Guice et al. Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis Ann. Surg. 210 6 1989 740 747
29. H. Akbarshahi et al. Acute lung injury in acute pancreatitis - awaiting the big leap Respir. Med. 106 9 2012 1199 1210
30. J.G. Norman et al. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction Dig. Dis. Sci. 42 8 1997 1783 1788
31. G. Alsfasser et al. Degradation and inactivation of plasma tumor necrosis factor-alpha by pancreatic proteases in experimental acute pancreatitis Pancreatology 5 1 2005 37 43 (discussion)
32. J. Norman et al. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE) J. Interf. Cytokine Res. 17 2 1997 113 118
33. E. Fisic et al. The role of IL-6, 8, and 10, sTNFr, CRP, and pancreatic elastase in the prediction of systemic complications in patients with acute pancreatitis Gastroenterol. Res. Pract. 2013 2013 282645
34. Z.G. Luan et al. Downregulation of HMGB1 protects against the development of acute lung injury after severe acute pancreatitis Immunobiology 218 10 2013 1261 1270
35. M. Rosas-Ballina, and K.J. Tracey Cholinergic control of inflammation J. Intern. Med. 265 6 2009 663 679